Drugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5 million jury verdict for Teva Pharmaceutical that found Lilly’s migraine drug Emgality infringed three patents related to Teva’s rival drug Ajovy.
Tag Archive for: Antibodies
Today the company said clinical trial data showed its updated COVID-19 vaccine will likely be effective against the highly-mutated BA.2.86 subvariant of the coronavirus that has raised fears of a resurgence of infections.
Both companies’ vaccines produced antibodies 14 days after the first of two shots and were detectable at varying levels in both children and adults for one year, data from the studies conducted in Western Africa showed.
Pfizer Inc. and its German partner BioNTech SE said their Omicron-tailored shot produced higher virus-neutralizing antibodies in older adults against the emerging subvariant BQ.1.1 than its original vaccine.
Vaccine maker Novavax Inc said on Tuesday its COVID-19 shot retooled against the Omicron BA.1 variant showed a strong immune response as the fourth dose and met the main goal of strain change in a late-stage study.
Omicron breakthrough infections may spare young hearts; no need to delay mammogram after vaccination
Antibodies, BioNTech, BNT162b2 (Pfizer and BioNTech), Breakthrough COVID-19, Cardiovascular, COVID-19 booster shots, COVID-19 shots, COVID-19 Studies, COVID-19 Vaccinations, COVID-19 Vaccines, Covid-19 Variants, Heart, Immune Cells, Immune Response, Lancet Infectious Diseases, Mammography, Messenger RNA (mRNA) Vaccines, Omicron (B.1.1.529) (South Africa), Pfizer, R&D, T-Cells, WomenThe Omicron variant of the coronavirus does not have a negative effect on cardiovascular health in young adults who have been vaccinated, a small study suggests. Additionally, women should not delay routine mammograms after receiving a COVID-19 mRNA vaccine, experts now say.
